In addition, in the hepatic steatosis model, only E6446, not the four candidate compounds, suppressed the accumulation of TG content, the formation of lipid droplets and the expression of C/ebpα, Fasn, and Fabp4 (Fig. 2F-H). This evidence concerns the gene CEBPA and fatty liver disease.